Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

RU.521

SKU: orb1301750

Description

RU.521

Research Area

Immunology & Inflammation

Images & Validation

Key Properties

CAS Number2262452-06-0
MW415.2
Purity>98%
FormulaC19H12Cl2N4O3
SMILESCc1nn(c(O)c1C1OC(=O)c2ccccc12)-c1nc2ccc(Cl)c(Cl)c2[nH]1
TargetSTING
SolubilitySoluble in DMSO (up to 25 mg/ml)

Bioactivity

Target IC50
THP-1-Dual cells:38.4 μM (CC50)|dsDNA:700 nM|H69AR cells:32.9 μM
In Vivo
METHODS: To study the effect of RU.521 on sepsis, mice were intraperitoneally injected with RU.521 (5 mg/kg) (injected with LPS) in a single dose. RESULTS: RU.521 enhanced cardiac function, reduced cardiac inflammation, oxidative stress and apoptosis, and alleviated the symptoms of sepsis in mice.
In Vitro
METHODS: Human THP1-Dual cells were treated with RU.521 for 24 hours, and the cytotoxicity was determined using the CCK-8 assay. RESULTS: RU.521 inhibited cell growth (CC50=38.4 μM).
Cell Research
Small-molecule compounds were serially diluted to concentrations spanning the range tested in the response curves were added to 6.7 × 10^5 RAW-Blue macrophages plated 16 h prior in 96-well dishes, then harvested 72 h after compound addition. ATP was measured using CellTiter Glo Viability Assay using 50 μM Tamoxifen as a positive control for cytotoxicity. Viability values were generated using vehicle (DMSO) or the first dose as 100% and Tamoxifen as 0%. Outliers were removed.
Animal Research
the chronically elevated levels of cytokines observed in Trex1 null mice are a consequence of constitutively activated cGAS, due to the inability to eliminate aberrantly localized self-DNA. We harvested BMDMs from 6–8-week old Trex1 / mice, treated them with each compound, and measured expression levels of IFNB1 by quantitative reverse transcription PCR (qRT-PCR). Treatment of primary BMDMs with RU.521 or its analogs reduced IFNB1 expression, indicating their effectiveness in suppressing intrinsic DNA-dependent, constitutively-activated type I interferon expression in cells deficient of a cytoplasmic DNA exonuclease.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

RU 320521, RU320521, RU-320521, RU.521, oxidative stress, signaling pathway, cGAS, dsDNA/cGAS, Cyclic GMP-AMP Synthase, inflammatory, inhibit, Inhibitor

Similar Products

  • RU320521 [orb1220930]

    >98% (HPLC)

    2262452-06-0

    414.22

    C19H11Cl2N4O3

    2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

5 mg
$ 240.00
25 mg
$ 510.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry